BELLEVUE, Wash.--(BUSINESS WIRE)--TerraPower Isotopes announced today it is producing actinium-225 1 at commercial-scale, providing sustained access to highly pure actinium-225 to the global ...
Researchers grew crystals of a pure actinium compound, seen here through a microscope, to understand how actinium binds to other molecules in a solid. The element actinium was first discovered at the ...
NEW YORK , June 7, 2023 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that it will be added ...
ATNM-400 demonstrated significant in vitro tumor cell killing when used in combination with AR-targeting agents, such as enzalutamide (Xtandi ®) The ATNM-400 enzalutamide combination produced superior ...
TerraPower Isotopes announced it is producing actinium-225 at commercial scale. The medical radioisotope is being produced from material recovered from a legacy uranium-233 inventory at a US national ...
- Median Overall Survival of 18.4 months with Actimab-A + CLAG-M in patients with relapsed or refractory AML who received 1 or 2 lines of prior therapy - Mutation agnostic potential of Actimab-A ...
Actinium Pharmaceuticals (ATNM) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results